Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional Results available

PF-04856884 (CVX-060) In Combination With Axitinib In Patients With Previously Treated Metastatic Renal Cell Carcinoma

ClinicalTrials.gov ID: NCT01441414

Public ClinicalTrials.gov record NCT01441414. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 24, 2026, 12:44 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A PHASE II TRIAL OF PF-04856884 (CVX-060), A SELECTIVE ANGIOPOIETIN-2 (ANG-2) INHIBITOR IN COMBINATION WITH AG-013736 (AXITINIB) IN PATIENTS WITH PREVIOUSLY TREATED METASTATIC RENAL CELL CARCINOMA

Study identification

NCT ID
NCT01441414
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Pfizer
Industry
Enrollment
18 participants

Conditions and interventions

Interventions

  • PF-04856884 Biological
  • Axitinib (AG-013736) Drug

Biological · Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 20, 2011
Primary completion
Mar 26, 2014
Completion
Mar 26, 2014
Last update posted
Jan 7, 2019

2011 – 2014

United States locations

U.S. sites
28
U.S. states
7
U.S. cities
20
Facility City State ZIP Site status
Pinnacle Oncology Hematology Scottsdale Arizona 85258
Arizona Oncology Associates, PC - HOPE Tucson Arizona 85704
Arizona Oncology Associates, PC-HOPE Tucson Arizona 85710
Rocky Mountain Cancer Centers Aurora Colorado 80012
Rocky Mountain Cancer Centers Boulder Colorado 80303
Rocky Mountain Cancer Centers Centennial Colorado 80112
Rocky Mountain Cancer Centers Colorado Springs Colorado 80907
Rocky Mountain Cancer Centers Colorado Springs Colorado 80909
Rocky Mountain Cancer Centers Denver Colorado 80218
Rocky Mountain Cancer Centers Denver Colorado 80220
Rocky Mountain Cancer Centers Lakewood Colorado 80228
Rocky Mountain Cancer Centers Littleton Colorado 80120-4413
Rocky Mountain Cancer Centers Lone Tree Colorado 80124
Rocky Mountain Cancer Centers Longmont Colorado 80501
Rocky Mountain Cancer Centers Parker Colorado 80138
Rocky Mountain Cancer Centers Pueblo Colorado 81008
Rocky Mountain Cancer Centers Thornton Colorado 80260
Nebraska Methodist Hospital Omaha Nebraska 68114
Comprehensive Cancer Centers of Nevada Henderson Nevada 89014
Comprehensive Cancer Centers of Nevada Henderson Nevada 89052
Comprehensive Cancer Centers of Nevada Henderson Nevada 89074
Comprehensive Cancer Centers of Nevada Las Vegas Nevada 89128
Comprehensive Cancer Centers of Nevada Las Vegas Nevada 89148
Comprehensive Cancer Centers of Nevada Las Vegas Nevada 89169
Regional Cancer Care-Durham Durham North Carolina 27704
Texas Oncology-Tyler Tyler Texas 75702
Seattle Cancer Care Alliance Seattle Washington 98109
University of Washington Medical Center Seattle Washington 98195

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01441414, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 7, 2019 · Synced Jul 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01441414 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →